filmov
tv
The ADVOCATE Trial: A Conversation with Dr. Peter A. Merkel
Показать описание
We have been fortunate to have several newly approved therapeutics for glomerular diseases over the past 5 years.
Dr. Peter Merkel discusses the ADVOCATE trial and the data behind Avacopan in this interview. He also discusses induction regimens for ANCA associated vasculitis and his thoughts on how
Avacopan fits into the expanding armamentarium nephrologists have in managing this disease process.
Visit us 👇
Dr. Peter Merkel discusses the ADVOCATE trial and the data behind Avacopan in this interview. He also discusses induction regimens for ANCA associated vasculitis and his thoughts on how
Avacopan fits into the expanding armamentarium nephrologists have in managing this disease process.
Visit us 👇
0:19:59
0:08:09
0:05:17
0:12:54
0:00:35
0:01:41
0:00:19
0:05:58
0:17:28
0:00:15
0:00:39
0:17:28
0:00:12
0:00:57
0:15:18
0:07:08
0:00:56
0:02:32
0:00:31
0:00:47
0:00:54
0:01:30
0:00:36
0:00:16